Protara Therapeutics Presents Results from Retrospective Analysis of Randomized and Open-Label Studies Evaluating the Safety and Efficacy of OK-432 in Patients with Lymphatic Malformations

Author's Avatar
Jul 01, 2022

Data showed OK-432 was clinically successful in treating lymphatic malformations and support a favorable safety profile